Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

What Are Best Practices for Ethical Use of Nanosensors for Worker Surveillance?

Marchant GE.

AMA J Ethics. 2019 Apr 1;21(4):E356-362. doi: 10.1001/amajethics.2019.356.

2.

Transgenerational epigenetics and environmental justice.

Rothstein MA, Harrell HL, Marchant GE.

Environ Epigenet. 2017 Aug 3;3(3):dvx011. doi: 10.1093/eep/dvx011. eCollection 2017 Jul. Review.

3.

Physicians' duty to recontact and update genetic advice.

Stevens YA, Senner GD, Marchant GE.

Per Med. 2017;14(4):367-374. doi: 10.2217/pme-2017-0012. Epub 2017 Jun 8.

4.

Big data in the era of precision medicine: big promise or big liability?

Issa AM, Marchant GE, Campos-Outcalt D.

Per Med. 2016 Jul;13(4):283-285. doi: 10.2217/pme-2016-0044. Epub 2016 May 25. No abstract available.

PMID:
29749809
5.

Contrasting Medical and Legal Standards of Evidence: A Precision Medicine Case Study.

Marchant GE, Scheckel K, Campos-Outcalt D.

J Law Med Ethics. 2016 Mar;44(1):194-204. doi: 10.1177/1073110516644210.

6.

A new window of opportunity to reject process-based biotechnology regulation.

Marchant GE, Stevens YA.

GM Crops Food. 2015;6(4):233-42. doi: 10.1080/21645698.2015.1134406.

7.

Predictive testing for Alzheimer's disease: suicidal ideation in healthy participants.

Caselli RJ, Marchant GE, Hunt KS, Henslin BR, Kosiorek HE, Langbaum J, Robert JS, Dueck AC.

Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):252-4. doi: 10.1097/WAD.0000000000000097. No abstract available.

8.

The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidence.

Issa AM, Chaudhari VS, Marchant GE.

Expert Rev Mol Diagn. 2015 Feb;15(2):277-86. doi: 10.1586/14737159.2015.983476. Epub 2014 Dec 5. Review.

9.

Public perceptions of presymptomatic testing for Alzheimer disease.

Caselli RJ, Langbaum J, Marchant GE, Lindor RA, Hunt KS, Henslin BR, Dueck AC, Robert JS.

Mayo Clin Proc. 2014 Oct;89(10):1389-96. doi: 10.1016/j.mayocp.2014.05.016. Epub 2014 Aug 26.

10.

Involuntary exposures to love-enhancing or anti-love agents.

Marchant GE, Stevens YA.

Am J Bioeth. 2013;13(11):26-7. doi: 10.1080/15265161.2013.839758. No abstract available.

PMID:
24161175
11.

Personalized medicine and genetic malpractice.

Marchant GE, Lindor RA.

Genet Med. 2013 Dec;15(12):921-2. doi: 10.1038/gim.2013.142. Epub 2013 Sep 26. No abstract available.

12.

The labeling debate in the United States.

Marchant GE, Cardineau GA.

GM Crops Food. 2013 Jul-Dec;4(3):126-34. doi: 10.4161/gmcr.26163. Epub 2013 Aug 26.

PMID:
23982076
13.

Regulatory and reimbursement innovation.

Lindor RA, Allocco SJ, Cheatham L, Cortese DA, Hall RF, Mangold WJ Jr, Pizziconi V, Poste G, Quinn B, Roth M, Saks MJ, Wassman ER, Woosley RL, Marchant GE.

Sci Transl Med. 2013 Mar 13;5(176):176cm3. doi: 10.1126/scitranslmed.3005437.

PMID:
23486776
14.

Prudent precaution in clinical trials of nanomedicines.

Marchant GE, Lindor RA.

J Law Med Ethics. 2012 Winter;40(4):831-40. doi: 10.1111/j.1748-720X.2012.00711.x.

PMID:
23289685
15.

Physician liability: the next big thing for personalized medicine?

Marchant GE, Campos-Outcalt DE, Lindor RA.

Per Med. 2011 Jul;8(4):457-467. doi: 10.2217/pme.11.33.

PMID:
29783333
16.

The benefits and challenges of a voluntary occupational exposure database.

Marchant GE, Crane A.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S52-6. doi: 10.1097/JOM.0b013e31821b175f.

PMID:
21654418
17.

What does the history of technology regulation teach us about nano oversight?

Marchant GE, Sylvester DJ, Abbott KW.

J Law Med Ethics. 2009 Winter;37(4):724-31. doi: 10.1111/j.1748-720X.2009.00443.x.

PMID:
20122112
18.

Editors' overview: forbidding science?

Marchant GE, Bird SJ.

Sci Eng Ethics. 2009 Sep;15(3):263-9. doi: 10.1007/s11948-009-9146-1. Epub 2009 Jun 27. No abstract available.

PMID:
19562518
19.

The ghost in our genes: legal and ethical implications of epigenetics.

Rothstein MA, Cai Y, Marchant GE.

Health Matrix Clevel. 2009 Winter;19(1):1-62.

20.

The problems with forbidding science.

Marchant GE, Pope LL.

Sci Eng Ethics. 2009 Sep;15(3):375-94. doi: 10.1007/s11948-009-9130-9. Epub 2009 Apr 7.

PMID:
19350416
21.

Ethical implications of epigenetics research.

Rothstein MA, Cai Y, Marchant GE.

Nat Rev Genet. 2009 Apr;10(4):224. doi: 10.1038/nrg2562. No abstract available.

22.

Hormesis and toxic torts.

Marchant GE.

Hum Exp Toxicol. 2008 Feb;27(2):97-107. doi: 10.1177/0960327107086567.

PMID:
18480129
23.

Transnational models for regulation of nanotechnology.

Marchant GE, Sylvester DJ.

J Law Med Ethics. 2006 Winter;34(4):714-25.

PMID:
17199813
24.

Legal pressures and incentives for personalized medicine.

Marchant GE, Milligan RJ, Wilhelmi B.

Per Med. 2006 Nov;3(4):391-397. doi: 10.2217/17410541.3.4.391.

PMID:
29788592
25.

Genetic samples and genetic philanthropy.

Berens ME, Marchant GE.

Virtual Mentor. 2004 Nov 1;6(11). pii: virtualmentor.2004.6.11.pfor2-0411. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411. No abstract available.

26.

From general policy to legal rule: aspirations and limitations of the precautionary principle.

Marchant GE.

Environ Health Perspect. 2003 Nov;111(14):1799-803. Review.

27.

Toxicogenomics and toxic torts.

Marchant GE.

Trends Biotechnol. 2002 Aug;20(8):329-32.

PMID:
12127279
28.
29.

Genetics and toxic torts.

Marchant GE.

Seton Hall Law Rev. 2001;31(4):949-82. No abstract available.

PMID:
11963951
30.

A synthetic vitreous fiber (SVF) occupational exposure database: implementing the SVF Health and Safety Partnership Program.

Marchant GE, Amen MA, Bullock CH, Carter CM, Johnson KA, Reynolds JW, Connelly FR, Crane AE.

Appl Occup Environ Hyg. 2002 Apr;17(4):276-85.

PMID:
11942671
31.

A regulatory precedent for hormesis.

Marchant GE.

Hum Exp Toxicol. 2001 Mar;20(3):143-4. No abstract available.

PMID:
11326778

Supplemental Content

Loading ...
Support Center